| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Department of Experimental Pathology, St. Bartholomew’s and The Royal London School of Medicine and Dentistry, London, United Kingdom
Genetic knock-out in mice of peroxisome proliferator-activated
receptor-
(PPAR) can prolong inflammation in response to
leukotriene B4. Although cyclooxygenase 2 has been
shown to be induced by PPAR activation, the effect of PPAR agonists on
the key inflammatory enzyme systems of nitric oxide synthase (NOS) and
stress proteins has not been investigated. The effect on these of
naturally occurring eicosanoid PPAR agonists (leukotriene
B4 and
8(S)-hydroxyeicosatetraenoic acid, which are
PPAR selective; PGA2, PGD2,
PGJ2, and 
12PGJ2, which are
PPAR
selective) and the synthetic PPAR agonist Wy14,643 was
examined in activated RAW264.7 murine macrophages. Leukotriene
B4 and
8(S)-hydroxyeicosatetraenoic acid stimulated
nitrite accumulation, indicative of enhanced NOS activity.
PGA2, PGD2, PGJ2,
12PGJ2, and Wy14,643 reduced nitrite
accumulation, with 12PGJ2 being the most
effective. The mechanism behind this reduction was examined using
Western blotting. Inhibition of nitrite accumulation was associated
with a fall in inducible NOS protein and an induction of heme oxygenase
1, correlating both dose dependently and temporally. Other proteins
examined (cyclooxygenase 2, heme oxygenase 2, heat shock protein 70,
and glucose-regulated protein 78) were unaffected. The data suggest
that naturally occurring PPAR agonists can inhibit the inducible NOS
enzyme pathway. This inhibition may be mediated by modulation of the
stress protein, heme oxygenase 1. Thus, the generation of eicosanoid
breakdown products during inflammation may contribute to its eventual
resolution by activation of the PPAR system. This system may thus
represent a novel target for therapeutic intervention in inflammatory
disease.
This article has been cited by other articles:
|
|
 |
|
  A. Tesse, G. Al-Massarani, R. Wangensteen, S. Reitenbach, M. C. Martinez, and R. Andriantsitohaina Rosiglitazone, a Peroxisome Proliferator-Activated Receptor-{gamma} Agonist, Prevents Microparticle-Induced Vascular Hyporeactivity through the Regulation of Proinflammatory Proteins J. Pharmacol. Exp. Ther., February 1, 2008; 324(2): 539 - 547. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Cuzzocrea, S. Bruscoli, E. Mazzon, C. Crisafulli, V. Donato, R. Di Paola, E. Velardi, E. Esposito, G. Nocentini, and C. Riccardi Peroxisome Proliferator-Activated Receptor-{alpha} Contributes to the Anti-Inflammatory Activity of Glucocorticoids Mol. Pharmacol., February 1, 2008; 73(2): 323 - 337. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Kronke, A. Kadl, E. Ikonomu, S. Bluml, A. Furnkranz, I. J. Sarembock, V. N. Bochkov, M. Exner, B. R. Binder, and N. Leitinger Expression of Heme Oxygenase-1 in Human Vascular Cells Is Regulated by Peroxisome Proliferator-Activated Receptors Arterioscler. Thromb. Vasc. Biol., June 1, 2007; 27(6): 1276 - 1282. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. T. Chambers, S. M. Weber, and J. A. Corbett PGJ2-stimulated beta-cell apoptosis is associated with prolonged UPR activation Am J Physiol Endocrinol Metab, April 1, 2007; 292(4): E1052 - E1061. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Marian, S. Baraldo, A. Visentin, A. Papi, M. Saetta, L. M. Fabbri, and P. Maestrelli Up-Regulated Membrane and Nuclear Leukotriene B4 Receptors in COPD Chest, June 1, 2006; 129(6): 1523 - 1530. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. H. Han, M. J. Quon, and K. K. Koh Beneficial Vascular and Metabolic Effects of Peroxisome Proliferator-Activated Receptor-{alpha} Activators Hypertension, November 1, 2005; 46(5): 1086 - 1092. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. B. E. Berry, J. A. Keelan, R. J. A. Helliwell, R. S. Gilmour, and M. D. Mitchell Nanomolar and Micromolar Effects of 15-Deoxy-{Delta}12,14-prostaglandin J2 on Amnion-Derived WISH Epithelial Cells: Differential Roles of Peroxisome Proliferator-Activated Receptors {gamma} and {delta} and Nuclear Factor {kappa}B Mol. Pharmacol., July 1, 2005; 68(1): 169 - 178. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. S. Goligorsky Endothelial cell dysfunction: can't live with it, how to live without it Am J Physiol Renal Physiol, May 1, 2005; 288(5): F871 - F880. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 X. Wang, R. L. Miyares, and G. P Ahern Oleoylethanolamide excites vagal sensory neurones, induces visceral pain and reduces short-term food intake in mice via capsaicin receptor TRPV1 J. Physiol., April 15, 2005; 564(2): 541 - 547. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Martinez, A. Perez-Castillo, and A. Santos The mitochondrial respiratory complex I is a target for 15-deoxy-{Delta}12,14-prostaglandin J2 action J. Lipid Res., April 1, 2005; 46(4): 736 - 743. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Abdelrahman, A. Sivarajah, and C. Thiemermann Beneficial effects of PPAR-{gamma} ligands in ischemia-reperfusion injury, inflammation and shock Cardiovasc Res, March 1, 2005; 65(4): 772 - 781. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. E. Camacho, L. Serneels, K. Spittaels, P. Merchiers, D. Dominguez, and B. De Strooper Peroxisome Proliferator-Activated Receptor {gamma} Induces a Clearance Mechanism for the Amyloid-{beta} Peptide J. Neurosci., December 1, 2004; 24(48): 10908 - 10917. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. M. Weber, K. T. Chambers, K. G. Bensch, A. L. Scarim, and J. A. Corbett PPAR{gamma} ligands induce ER stress in pancreatic {beta}-cells: ER stress activation results in attenuation of cytokine signaling Am J Physiol Endocrinol Metab, December 1, 2004; 287(6): E1171 - E1177. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S.-Y. Lim, J.-H. Jang, H.-K. Na, S. C. Lu, I. Rahman, and Y.-J. Surh 15-Deoxy-{Delta}12,14-Prostaglandin J2 Protects against Nitrosative PC12 Cell Death through Up-regulation of Intracellular Glutathione Synthesis J. Biol. Chem., October 29, 2004; 279(44): 46263 - 46270. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. F. Watts and B. Staels Regulation of Endothelial Nitric Oxide Synthase by PPAR Agonists: Molecular and Clinical Perspectives Arterioscler. Thromb. Vasc. Biol., April 1, 2004; 24(4): 619 - 621. [Full Text] [PDF]
|
|
|
|
|
|
S. M. Weber, A. L. Scarim, and J. A. Corbett PPAR{gamma} is not required for the inhibitory actions of PGJ2 on cytokine signaling in pancreatic {beta}-cells Am J Physiol Endocrinol Metab, March 1, 2004; 286(3): E329 - E336. [Abstract] [Full Text]
|
|
|
|
|
|
G. Kronke, V. N. Bochkov, J. Huber, F. Gruber, S. Bluml, A. Furnkranz, A. Kadl, B. R. Binder, and N. Leitinger Oxidized Phospholipids Induce Expression of Human Heme Oxygenase-1 Involving Activation of cAMP-responsive Element-binding Protein J. Biol. Chem., December 19, 2003; 278(51): 51006 - 51014. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. OSTERUD and E. BJORKLID Role of Monocytes in Atherogenesis Physiol Rev, October 1, 2003; 83(4): 1069 - 1112. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T.-S. Lee, H.-L. Tsai, and L.-Y. Chau Induction of Heme Oxygenase-1 Expression in Murine Macrophages Is Essential for the Anti-inflammatory Effect of Low Dose 15-Deoxy-{Delta}12,14-prostaglandin J2 J. Biol. Chem., May 23, 2003; 278(21): 19325 - 19330. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. M. Weber, A. L. Scarim, and J. A. Corbett Inhibition of IFN-gamma -induced STAT1 activation by 15- deoxy-Delta 12,14-prostaglandin J2 Am J Physiol Endocrinol Metab, May 1, 2003; 284(5): E883 - E891. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Cernuda-Morollon, F. Rodriguez-Pascual, P. Klatt, S. Lamas, and D. Perez-Sala PPAR Agonists Amplify iNOS Expression While Inhibiting NF-{kappa}B: Implications for Mesangial Cell Activation by Cytokines J. Am. Soc. Nephrol., September 1, 2002; 13(9): 2223 - 2231. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Reynolds, B. Novosad, A. Hoffhines, J. Gipson, J. Johnson, J. Peters, F. Gonzalez, J. Gimble, and M. Hill Pretreatment with troglitazone decreases lethality during endotoxemia in mice Innate Immunity, August 1, 2002; 8(4): 307 - 314. [Abstract] [PDF]
|
|
|
|
|
|
S. Cuzzocrea, N. S. Wayman, E. Mazzon, L. Dugo, R. Di Paola, I. Serraino, D. Britti, P. K. Chatterjee, A. P. Caputi, and C. Thiemermann The Cyclopentenone Prostaglandin 15-Deoxy-Delta 12,14-Prostaglandin J2 Attenuates the Development of Acute and Chronic Inflammation Mol. Pharmacol., May 1, 2002; 61(5): 997 - 1007. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. G. Alleva, E. B Johnson, F. M Lio, S. A Boehme, P. J Conlon, and P. D. Crowe Regulation of murine macrophage proinflammatory and anti-inflammatory cytokines by ligands for peroxisome proliferator-activated receptor-{gamma}: counter-regulatory activity by IFN-{gamma} J. Leukoc. Biol., April 1, 2002; 71(4): 677 - 685. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. B. Clark The role of PPARs in inflammation and immunity J. Leukoc. Biol., March 1, 2002; 71(3): 388 - 400. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. G. Harris, R. S. Smith, and R. P. Phipps 15-Deoxy-{Delta}12,1412,14-PGJ2 Induces IL-8 Production in Human T Cells by a Mitogen-Activated Protein Kinase Pathway J. Immunol., February 1, 2002; 168(3): 1372 - 1379. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M.-A. Simonin, K. Bordji, S. Boyault, A. Bianchi, E. Gouze, P. Becuwe, M. Dauca, P. Netter, and B. Terlain PPAR-gamma ligands modulate effects of LPS in stimulated rat synovial fibroblasts Am J Physiol Cell Physiol, January 1, 2002; 282(1): C125 - C133. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Tanaka, H. Kohno, S.-i. Yoshitani, S. Takashima, A. Okumura, A. Murakami, and M. Hosokawa Ligands for Peroxisome Proliferator-activated Receptors {{alpha}} and {{gamma}} Inhibit Chemically Induced Colitis and Formation of Aberrant Crypt Foci in Rats1 Cancer Res., March 1, 2001; 61(6): 2424 - 2428. [Abstract] [Full Text]
|
|
|
|
 |
|
 T. Claudel, M. D. Leibowitz, C. Fiévet, A. Tailleux, B. Wagner, J. J. Repa, G. Torpier, J.-M. Lobaccaro, J. R. Paterniti, D. J. Mangelsdorf, et al. Reduction of atherosclerosis in apolipoprotein E knockout mice by activation of the retinoid X receptor PNAS, February 15, 2001; (2001) 41609298. [Abstract] [Full Text]
|
|
|
|
 |
|
 A. VON KNETHEN and B. BRUNE Delayed activation of PPAR{gamma} by LPS and IFN-{gamma} attenuates the oxidative burst in macrophages FASEB J, February 1, 2001; 15(2): 535 - 544. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M Cavicchi, L Gibbs, and B J R Whittle Inhibition of inducible nitric oxide synthase in the human intestinal epithelial cell line, DLD-1, by the inducers of heme oxygenase 1, bismuth salts, heme, and nitric oxide donors Gut, December 1, 2000; 47(6): 771 - 778. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. T. Heneka, T. Klockgether, and D. L. Feinstein Peroxisome Proliferator-Activated Receptor-gamma Ligands Reduce Neuronal Inducible Nitric Oxide Synthase Expression and Cell Death In Vivo J. Neurosci., September 15, 2000; 20(18): 6862 - 6867. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. N. Ajuebor, A. Singh, and J. L. Wallace Cyclooxygenase-2-derived prostaglandin D2 is an early anti-inflammatory signal in experimental colitis Am J Physiol Gastrointest Liver Physiol, July 1, 2000; 279(1): G238 - G244. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
U. Ikeda, M. Shimpo, Y. Murakami, and K. Shimada Peroxisome Proliferator-Activated Receptor-{gamma} Ligands Inhibit Nitric Oxide Synthesis in Vascular Smooth Muscle Cells Hypertension, June 1, 2000; 35(6): 1232 - 1236. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Bordji, J.-P. Grillasca, J.-N. Gouze, J. Magdalou, H. Schohn, J.-M. Keller, A. Bianchi, M. Dauca, P. Netter, and B. Terlain Evidence for the Presence of Peroxisome Proliferator-activated Receptor (PPAR) alpha and gamma and Retinoid Z Receptor in Cartilage. PPARgamma ACTIVATION MODULATES THE EFFECTS OF INTERLEUKIN-1beta ON RAT CHONDROCYTES J. Biol. Chem., April 14, 2000; 275(16): 12243 - 12250. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Castrillo, M. J. M. Díaz-Guerra, S. Hortelano, P. Martín-Sanz, and L. Boscá Inhibition of Ikappa B Kinase and Ikappa B Phosphorylation by 15-Deoxy-Delta 12,14-Prostaglandin J2 in Activated Murine Macrophages Mol. Cell. Biol., March 1, 2000; 20(5): 1692 - 1698. [Abstract] [Full Text]
|
|
|
|
|
|
R. B. Clark, D. Bishop-Bailey, T. Estrada-Hernandez, T. Hla, L. Puddington, and S. J. Padula The Nuclear Receptor PPAR{gamma} and Immunoregulation: PPAR{gamma} Mediates Inhibition of Helper T Cell Responses J. Immunol., February 1, 2000; 164(3): 1364 - 1371. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. M. Reilly, J. C. Oates, J. A. Cook, J. D. Morrow, P. V. Halushka, and G. S. Gilkeson Inhibition of Mesangial Cell Nitric Oxide in MRL/lpr Mice by Prostaglandin J2 and Proliferator Activation Receptor-{gamma} Agonists J. Immunol., February 1, 2000; 164(3): 1498 - 1504. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Delerive, K. De Bosscher, S. Besnard, W. Vanden Berghe, J. M. Peters, F. J. Gonzalez, J.-C. Fruchart, A. Tedgui, G. Haegeman, and B. Staels Peroxisome Proliferator-activated Receptor alpha Negatively Regulates the Vascular Inflammatory Gene Response by Negative Cross-talk with Transcription Factors NF-kappa B and AP-1 J. Biol. Chem., November 5, 1999; 274(45): 32048 - 32054. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Klocker, P. Kermer, M. Gleichmann, M. Weller, and M. Bahr Both the Neuronal and Inducible Isoforms Contribute to Upregulation of Retinal Nitric Oxide Synthase Activity by Brain-Derived Neurotrophic Factor J. Neurosci., October 1, 1999; 19(19): 8517 - 8527. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Callejas, M Casado, L Bosca, and P Martin-Sanz Requirement of nuclear factor kappaB for the constitutive expression of nitric oxide synthase-2 and cyclooxygenase-2 in rat trophoblasts J. Cell Sci., January 9, 1999; 112(18): 3147 - 3155. [Abstract] [PDF]
|
|
|
|
|
|
P. Gervois, N. Vu-Dac, R. Kleemann, M. Kockx, G. Dubois, B. Laine, V. Kosykh, J.-C. Fruchart, T. Kooistra, and B. Staels Negative Regulation of Human Fibrinogen Gene Expression by Peroxisome Proliferator-activated Receptor alpha Agonists via Inhibition of CCAAT Box/Enhancer-binding Protein beta J. Biol. Chem., August 31, 2001; 276(36): 33471 - 33477. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Claudel, M. D. Leibowitz, C. Fievet, A. Tailleux, B. Wagner, J. J. Repa, G. Torpier, J.-M. Lobaccaro, J. R. Paterniti, D. J. Mangelsdorf, et al. Reduction of atherosclerosis in apolipoprotein E knockout mice by activation of the retinoid X receptor PNAS, February 27, 2001; 98(5): 2610 - 2615. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
